Subscribe
istock-949432696-artur
Artur / iStockphoto.com
23 October 2018Americas

United Therapeutics signs 3D bioprinting technology deal

Maryland-based United Therapeutics has inked a licence, development and commercialisation agreement with CollPlant, an Israeli biotech company, for 3D bioprinted lung transplants.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Asia
3D Bioprinting: Can India capitalise on a growing trend?
1 August 2023   Amid worldwide interest, India could position itself as a global hub for a desperately needed technology, say Kavita Arora and Shaivya Dhawan of K&S Partners.


Editor's picks

In-house with Bayer: ‘Focus on quality early and stay close to inventors’
Europe
In-house with Bayer: ‘Focus on quality early and stay close to inventors’
15 July 2025

Editor's picks

Europe
In-house with Bayer: ‘Focus on quality early and stay close to inventors’
15 July 2025
Europe
UKIPO rejects Boehringer’s SPC for horse inhaler
8 July 2025
Europe
‘We created law’: G1/24 and the creation of the ‘diamond standard’
3 July 2025
Americas
Bankruptcy judge approves $305m sale of genetics testing company
1 July 2025
Americas
A step too far? Why Stewart’s approach is dividing opinion
24 June 2025
Europe
Diverging in the detail: UPC local divisions and Court of Appeal take different paths
19 June 2025

More on this story

Asia
3D Bioprinting: Can India capitalise on a growing trend?
1 August 2023   Amid worldwide interest, India could position itself as a global hub for a desperately needed technology, say Kavita Arora and Shaivya Dhawan of K&S Partners.

More on this story

Asia
3D Bioprinting: Can India capitalise on a growing trend?
1 August 2023   Amid worldwide interest, India could position itself as a global hub for a desperately needed technology, say Kavita Arora and Shaivya Dhawan of K&S Partners.

More features

AbbVie blocks Humira antitrust suit
WATCH: Enabling success—mastering s112 in the new era of life sciences patents
AstraZeneca suffers defeat over $7bn diabetes patent
US firm Brownstein nabs five from Crowell ‘at pivotal moment’
American Regent secures rare PI win in Hatch-Waxman dispute
WATCH: Patents s101—how to overcome the current complexity of patent eligibility in the US
In-house with Bayer: ‘Focus on quality early and stay close to inventors’
Explainer: ARIPO’s role in Plant Variety Protection